SCHEMBL5828689

SCHEMBL5828689

COc1cc2c(/N=C(\NCC(=O)O)Nc3c(C)cccc3C)ncnc2cc1OCCN1CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 9/20 0.52
KDR P35968 6/20 0.51
BRAF P15056 5/20 0.50
AURKA O14965 3/20 0.49
RET P07949 2/20 0.49
AURKB Q96GD4 2/20 0.49
ROCK2 O75116 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LCK P06239 1/20 0.49
FYN P06241 1/20 0.49
MET P08581 1/20 0.49
MAPT P10636 1/20 0.49
SRC P12931 1/20 0.49
PDGFRA P16234 1/20 0.49
LTK P29376 1/20 0.49
TTK P33981 1/20 0.49
MAP2K2 P36507 1/20 0.49
MAP2K1 Q02750 1/20 0.49
BTK Q06187 1/20 0.49
TYRO3 Q06418 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5828691 1.00 EGFR (0.52) EGFRKDRBRAFAURKARET
SCHEMBL5828263 0.93 PDGFRB (0.52) EGFRKDRBRAFRETPDGFRB
SCHEMBL5828257 0.93 PDGFRB (0.52) EGFRKDRBRAFRETPDGFRB
SCHEMBL5828139 0.92 EGFR (0.50) EGFRKDRBRAFAURKARET
SCHEMBL5828140 0.92 EGFR (0.50) EGFRKDRBRAFAURKARET
SCHEMBL5829015 0.89 KDR (0.53) EGFRKDRBRAFAURKARET
SCHEMBL5829010 0.89 KDR (0.53) EGFRKDRBRAFAURKARET
SCHEMBL6984966 0.87 EGFR (0.58) EGFRKDRBRAFAURKARET
SCHEMBL6985218 0.86 KDR (0.53) EGFRKDRBRAFAURKARET
SCHEMBL5828456 0.86 KDR (0.53) EGFRKDRBRAFAURKARET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed
EP-1296973-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AstraZeneca AB (SE) 2003-04-02 EP disclosed
WO-2002000644-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2002-01-03 WO disclosed